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ABSTRACT
Background
Although stroke mortality in developing countries is more than 85%, the case fatality in Uganda is not
known.
Objective
We determined 30 day case fatality, associated clinical and laboratory presentations among adult stroke




Mulago national referral hospital, Kampala, Uganda
Participants
Stroke patients presenting from July 2010 to January 2011.
Intervention
Patients  presenting  to  the  accident  and  emergency  with  stroke  confirmed  on  brain  computerised
tomography (CT) scan were recruited consecutively and subsequently transferred to the neurology unit.
Selected social demographics, clinical and laboratory presentations were obtained. Supportive care, specific
treatment and rehabilitation services were offered to the participants.
Main Outcome Measures
Case fatality rate at 30 days
Results
Out of 150 eligible participants, 17 declined, 133 were enrolled into the study but 5 were lost to follow up.
Data from 128 participants were analysed. The mean age was 62.3+15.7 years and 58.0% were females.
Ischemic and haemorrhagic stroke contributed 79% and 21% respectively. Majority of participants 97 (76%)
had only motor deficits and 78 (61%) had impaired consciousness. More than half of participants had high
blood pressure at  admission,  with diastolic  and systolic  hypertension among 106 (83%) and 68 (53%)
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respectively. Forty eight (38%) participants had hyperglycemia, 42 (33%) leucocytosis, 13% elevated low
density lipoprotein and 9% high triglycerides.  No participant  with ischemic stroke presented in time for
thrombolysis.  The  30  day case  fatality  was  43.8% and  factors  independently associated  with  it  were
Glasgow coma scale (GCS) < 9 p = 0.001and age 51-60 years P=0.044.
Conclusion
Thirty-day case fatality was high. Poor prognostic factors  were GCS of  <9 and age 51-60 years.  Early
presentation to hospital, intensive management, implementation of treatment guidelines and measures to
prevent stroke should be emphasised.
INTRODUCTION
Stroke is becoming a serious problem in public health in developing countries, Uganda inclusive, accounting
for 85% of global deaths (2, 5, 7, 8, 13, 26, 27, 28, 29). Stroke severity, its associated complications, and lack
of stroke units contribute to the high mortality rate found to be as high as 62% at one year (9, 14, 20, 21, 22,
30, 31). Despite this, there is very limited data on stroke mortality in sub-Saharan Africa, and to the best of
our knowledge there are no published data on stroke mortality in Uganda. In this study, we reported the 30
day stroke mortality and associated clinical and laboratory presentations among adult patients admitted with
stroke at Mulago hospital in Uganda.
METHODS
Setting: Mulago Hospital is Uganda’s national referral hospital and Makerere University College of Health
Sciences’ teaching hospital. It is located in Kampala and has an estimated bed capacity of 1,500. It has an
accident and emergency unit, intensive care unit, clinical laboratory, radiology department with a CT scan and
highly trained radiologists, neurology, neurosurgery and physiotherapy units.
Study period: During a six  months period from 1st  July 2010 to 30th January 2011, 167 patients who
presented to Mulago hospital’s accident and emergency unit  with neurologic deficits suggestive of  acute
stroke (29)  were screened. Computerised tomography scan of  the brain was done to confirm stroke by
radiologists with experience in this field. Classification of stroke subtypes was done using the Trial of ORG
10172 and medical disability guidelines for ischemic and hemorrhagic stroke respectively (1, 17). Patients
who had a normal brain CT scan, had a repeat done on day 7 and were excluded in case it was still normal.
Participants with confirmed stroke were approached for enrolment into the study. Those that consented were
recruited consecutively. An interviewer based questionnaire was administered by the principal investigator
and trained research assistants.  Selected social  demographic  characteristics,  medical  history relevant to
stroke  and  a  comprehensive  clinical  examination  was  done.  Blood  samples  for  essential  laboratory
investigations (complete blood count, erythrocyte sedimentation rate, fasting lipid profile and blood sugar, HIV
serology and rapid plasma reagin) were obtained. These patients were reviewed every two days from the day
of admission while on the ward until discharge. Upon admission, the patients were managed on the accident
and emergency unit, and general neurology unit by a neurologist, internal medicine physicians, nurses and
auxiliary staffs. They received supportive treatment which included ensuring a patent airway, good oxygen
saturation,  haemodynamic stability,  nutrition,  hydration, temperature and glycaemic control,  prevention of
deep  vein  thrombosis  and  pressure  sores.  Specific  treatment  included  use  of  antihypertensive  drugs
(labetalol and hydralazine) when blood pressure exceeded 180/105mmHg and 160/100mmHg for ischemic
and haemorrhagic stroke respectively. Antiplatelet drugs including aspirin and clopidogrel for ischemic stroke
and statins were administered. Rehabilitation included physiotherapy, occupational, speech and language
therapy. Those that required mechanical ventilation were admitted to the intensive care unit. None of the
patients  with  ischemic  stroke  benefitted  from  recombinant  tissue  plasminogen  activator  because  they
presented on average 2 days post ictal. On discharge, they were then scheduled for a neurology outpatient
clinic visit that coincided with the 30th day from the date of stroke onset. Participants that did not turn up for
the scheduled visit were then contacted by telephone (contacts of three immediate relatives) to ascertain
whether they were still alive or dead. Participants who died within 30 days of stroke onset were recorded.
RESULTS
One hundred and sixty seven patients who presented to Mulago hospital’s accident and emergency unit with
neurologic deficits suggestive of acute stroke (29) were screened. One hundred and fifty patients, 18 years
and above, were confirmed to have stroke on brain CT scan. Seventeen patients declined to consent for
participation in the study and 133 patients were enrolled consecutively into the study. Five participants were
lost to follow up and therefore data from 128 participants were analysed. At the end of the follow up period of
30 days from stroke onset, 56 (43.8%) participants had died while 72 (56.2%) were still alive. Stroke mortality
was not stratified at 24 hours and seven days from stroke onset as this preliminary study only established
stroke mortality at 30 days among adult stroke patients admitted at Mulago hospital.
The mean age of the participants was 62.3+15.7 years with a median of 64.5 and 58% were female. Fifty six
percent of  the participants had never had formal education, 38% were Catholic and 66% were married.
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Twenty one (15.8%) were taking alcohol while only 3 (2.3%) were current  smokers.  Social demographic
characteristics are presented in Table 1.
Majority of the participants 105 (79%) had ischemic stroke and 28 (21%) had hemorrhagic stroke. All study
participants presented with focal  neurological  deficits,  with majority 97 (76%) presenting with  only motor
deficits. Impaired level of consciousness was present in 78 (61%) patients. More than 50% of the participants
had high blood pressure at admission with diastolic and systolic hypertension found among 106(83%) and 68
(53%) respectively. Eighty four (66%) were aware of their hypertension. The clinical characteristics of the
study participants are presented in Table 2.
Most patients 103(80.47%) had haemoglobin levels less than 11.5g/dl followed by hyperglycaemia of more
than 7.0 mmol/l in 48 (38%) and leucocytosis in 42 (33%) patients. The laboratory presentations of the study
participants are presented in Table 3.
Clinical and laboratory parameters that were significantly associated with mortality at bivariate analysis with
P- value set at < 0.05 were entered into the multivariate linear logistic regression model. Factors that were
significantly associated with 30 day stroke mortality were; age 51-60 years with OR 0.18 (95% CI; 0.04- 0.82)
p value 0.044 and Glasgow coma scale < 9 OR 0.13 (95%CI; 0.05-0.25) p value <0.001. Temperature,
though not  statistically  significant  at  multivariate  analysis,  it  was  associated  with  increased  mortality  at
bivariate  analysis  OR 2.81 (95%CI;  1.2-6.60)  P<0.005. On the other  hand, though mortality was higher
among patients with hemorrhagic stroke (54%) compared to ischemic stroke (41%), there was no statistically
significant difference at bivariate analysis OR 1.71 (95% CI 0.68-4.27). Factors significantly associated with
30 day stroke mortality are presented in Table 4.
DISCUSSION
Stroke has been demonstrated in this study as a challenge among patients admitted to Mulago hospital. The
majority of patients in this study were female 74 (58%). They were also relatively young with mean age of
62.3years similar to other studies in sub-Saharan Africa (21) unlike in the West where the mean age is above
75years (30).
The 30-day mortality among stroke patients was 43.8% which is similar to other hospital based stroke case
fatality studies in Africa: 54% in Gambia, 33.6% in Nigeria and 49.6% in Maputo Mozambique (6, 10, 20, 21,
22, 25).
However  in  developed countries  where  patients  present  early  following  stroke  and  care  takes  place  in
specialized stroke units, the 30-day stroke mortality is much lower. A study done in Toronto, Canada showed
30 day mortality among stroke patients of 20% (30).
Majority of the patients presented with history of loss of consciousness 78 (61 %), Glasgow coma scale less
than 9, 38(30 %) and diastolic  hypertension 106 (83%) which is  comparable with other studies done in
resource limited countries (3). A Glasgow coma scale score of less than 9 was associated with increased
mortality which is also comparable with other studies done on stroke mortality (23, 30).
Regarding stroke subtypes, majority of the patients had ischemic stroke (79%), mortality was higher among
those with hemorrhagic stroke, however there was no statistically significant difference in mortality between
hemorrhagic and ischemic stroke. This is in contrast to other studies, which demonstrated a higher mortality
among patients with hemorrhagic stroke (20, 23). In this study, probably we needed a bigger sample size to
conclusively come up with a more realistic association.
In this study, patients who were between the ages of 51 and 60 years (6th decade) had a higher 30 day
stroke mortality rate compared to those who were below 51 and above 60 years. However, those above 70
years of age had the highest 30 day mortality rate which is similar to other studies that showed mortality
worsens with advancing age (30).  Smoking and alcohol use were not associated with increased 30 day
stroke mortality among the study participants which is similar to other studies (4). Studies on 30 day stroke
mortality and associated factors demonstrated a trend that hyperpyrexia worsens stroke mortality (11, 12).
This trend was not sustained at multivariate analysis.
Prevalence of HIV among stroke patients was 12%, which is higher compared to 5.8% in an earlier study
done  in  Mulago  among  stroke  patients  in  2007  (19).  In  the  general  population  the  average  HIV
seroprevalence in Uganda is 7.3% as reported by Ministry of Health, Uganda (24). At Mulago hospital, HIV
seroprevalence on the medical wards currently stands at 50 % (16). The HIV seroprevalence among our
study participants was much lower than reported from studies done in Muhimbili,  Tanzania and Blantyre,
Malawi 20.9% and 48% respectively (15, 18). In these two studies, the average mean age of the patients was
47years, which is lower than the mean age in our study which was 63.3 years.
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CONCLUSION
Thirty day mortality among adult stroke patients admitted at Mulago hospital was 43.8%. Delay in hospital
presentation and lack  of  organised inpatient  stroke care (stroke  units)  is  likely responsible for  this  high
mortality. Poor prognostic factors for 30 day stroke mortality in our study population were GCS of <9 and age
51-60 years. Future studies should be directed towards increasing stroke prevention and public recognition of
stroke to enhance early presentation to hospital as well as setting up organised inpatient stroke care facilities
to decrease morbidity and mortality from stroke.
Conflit d’intérêt : Aucun 
Table 1: Social demographic characteristics of the study participants
Characteristics Frequency N=128 Percentage 
Age 
<51 32 25 
51-60 24 19 
61-70 35 27 
>71 37 29 
Gender 
Male 54 42 
Female 74 58 
Level of education 
None 71 56 
Primary 17 13 
Secondary 21 16 
Tertiary 19 15 
Religion 
Catholic 48 38 
Protestant 41 32 
Moslem 28 22 
Others 11 09 
Marital status 
Single 07 06 
Married 84 66 
Divorced 06 05 
Widowed 31 24 
Life style 
Smoker 3 02 
Alcohol consumption 21 16 
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Table 2: Clinical presentation of the study participants
Variable Frequency N = 128 Percentage 
Symptom 
Sudden trouble in walking 108 84 
Sudden weakness of the face 109 85 
Sudden numbness of the face 80 63 
Sudden onset of vomiting 37 29 
Loss of consciousness 78 61 
Past medical history 
Diabetes 26 20 
Heart disease 14 11 
Antihypertensive drugs 84 66 
Antiplatelet drugs 23 18 
Anticoagulants 3 2 
Physical examination 
Glasgow coma scale <9 38 30 
Glasgow coma scale >9 90 70 
Motor 97 76 
Sensory 2 6 
Motor & sensory 29 22 
Blood pressure 
Systolic >140mmHg 68 53 
Systolic <140mmHg 60 47 
Diastolic >90mmHg 106 83 
Diastolic <90mmHg 22 17 
Irregular pulse 17 13 
Stroke subtype 
Ischemic 105 79 
Hemorrhagic 28 21 
Table 3: Laboratory presentation of study participants
Variable Frequency N=128 Percentage 
Complete blood cell count 
WBC count 
>11,000 42 33 
<11,000 86 67 
Platelet count 
>450 9 7 
<450 199 93 
Haemoglobin (g/dl) 
>11.5 25 20 
<11.5 103 80 
HIV serology 
Reactive 15 12 
Non-reactive 113 88 
Blood sugar 
>7mmol/L 48 38 
<7mmol/L 80 62 
Fasting lipid profile 
LDL 
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Variable Frequency N=128 Percentage 
High 17 13 
Normal 111 87 
HDL 
Low 50 39 
Normal 78 61 
Triglycerides 
High 11 9 
Normal 117 91 
Total cholesterol 
High 46 36 
Normal 82 64 
TPPA 
Positive 15 12 
Negative 113 88 







AOR 95%CI P value 
Gender 
Male 34(63.0) 20(37.0) 1 
Female 38(51.0) 36(49.0) 1.7 0.67-4.27 0.261 
Age group (years) 
<51 19(59.0) 13(41.0) 1 
51-60 21(87.0) 03(13.0) 0.16 0.03-0.95 0.044* 
61-70 18(51.0) 17(49.0) 0.96 0.31-3.00 0.95 
71+ 14(38.0) 23(62.0) 1.9 0.62-5.84 0.26 
Glasgow coma 
<9 09(24.0) 29(76.0) 1 
>9 63(70.0) 27(30.0) 0.15 0.05-0.43 0.001* 
Temperature (0C) 
< 37.5 59(62.0) 35(37.0) 1 
>37.5 12(38.0) 20(63.0) 2.2 0.71-6.52 0.137 
ESR 
<20 25(66.0) 13(34.0) 1 
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